+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Elimination of leukemic cells from autologous bone marrow grafts with antibody ricin conjugates



Elimination of leukemic cells from autologous bone marrow grafts with antibody ricin conjugates



Experimental Hematology 11(Suppl. 14): 186




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028244223

Download citation: RISBibTeXText


Related references

Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates. Cancer Research 46(3): 1208-1213, 1986

Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation. Blood 65(5): 1149-1157, 1985

Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxin. Blood 65(2): 289-297, 1985

Immunophenotype ricin sensitivity of leukemic t lineage marrow progenitor cells in acute lymphocytic leukemia and the therapeutic potential of intact ricin immunotoxins in autologous bone marrow transplantation for t acute lymphocytic leukemia lymphoblastic lymphoma. Journal of Cellular Biochemistry Suppl. (10 Part B): 78, 1986

Residual leukemic cells in autologous marrow grafts do not significantly contribute to leukemia relapse after bone marrow transplantation. Experimental Hematology 16(6): 492, 1988

Elimination of B-lineage leukemia and lymphoma cells from bone marrow grafts using anti-B4-blocked-ricin immunotoxin. Journal Of Clinical Immunology. 15(1): 51-57, 1995

Transferrin ricin a chain for ex vivo purging of small cell carcinoma cells from autologous bone marrow grafts. Clinical Research 38(1): 17A, 1990

Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies. Nouvelle Revue Francaise d'Hematologie 28(2): 97-105, 1986

Modeling autologous bone marrow transplantation in leukemia and the inhibition of leukemic cells in grafts. Eksperimental'naya Onkologiya 13(3): 39-42, 1991

Selective elimination of leukemic cells by merocyanine 540 in autologous bone marrow transplantation purging procedures. Bone: 286, 1986

Elimination of leukemic cells from rat bone marrow using antibody and complement. Cancer Research 41(9 Pt 1): 3331-3335, 1981

Elimination of residual tumor cells from autologous bone marrow grafts using monoclonal antibodies. Oldham, R K (Ed ) Principles Of Cancer Biotherapy X+502p Raven Press: New York, New York, Usa Illus 355-384, 1987

Ex vivo bone marrow treatment with immunotoxin anti t cell monoclonal antibody ricin conjugates for prevention of graft vs. host disease in allogeneic bone marrow transplantation. Experimental Hematology 12(6): 411, 1984